BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

468 related articles for article (PubMed ID: 33042518)

  • 1. Recent advances in treating oesophageal cancer.
    Harada K; Rogers JE; Iwatsuki M; Yamashita K; Baba H; Ajani JA
    F1000Res; 2020; 9():. PubMed ID: 33042518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular landscape of esophageal cancer: implications for early detection and personalized therapy.
    Talukdar FR; di Pietro M; Secrier M; Moehler M; Goepfert K; Lima SSC; Pinto LFR; Hendricks D; Parker MI; Herceg Z
    Ann N Y Acad Sci; 2018 Dec; 1434(1):342-359. PubMed ID: 29917250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approach to Localized Squamous Cell Cancer of the Esophagus.
    Weidenbaum C; Gibson MK
    Curr Treat Options Oncol; 2022 Oct; 23(10):1370-1387. PubMed ID: 36042147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advances in diagnosis and management of cancer of the esophagus.
    Deboever N; Jones CM; Yamashita K; Ajani JA; Hofstetter WL
    BMJ; 2024 Jun; 385():e074962. PubMed ID: 38830686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
    Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
    Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and translational advances in esophageal squamous cell carcinoma.
    Reichenbach ZW; Murray MG; Saxena R; Farkas D; Karassik EG; Klochkova A; Patel K; Tice C; Hall TM; Gang J; Parkman HP; Ward SJ; Tétreault MP; Whelan KA
    Adv Cancer Res; 2019; 144():95-135. PubMed ID: 31349905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Esophageal cancer: emerging therapeutics.
    Rogers JE; Sewastjanow-Silva M; Waters RE; Ajani JA
    Expert Opin Ther Targets; 2022 Feb; 26(2):107-117. PubMed ID: 35119973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The management of localized esophageal squamous cell carcinoma: Western approach.
    Zaidi N; Kelly RJ
    Chin Clin Oncol; 2017 Oct; 6(5):46. PubMed ID: 29129086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic risk factors for esophageal squamous cell carcinoma and adenocarcinoma: a prospective study of 580,000 subjects within the Me-Can project.
    Lindkvist B; Johansen D; Stocks T; Concin H; Bjørge T; Almquist M; Häggström C; Engeland A; Hallmans G; Nagel G; Jonsson H; Selmer R; Ulmer H; Tretli S; Stattin P; Manjer J
    BMC Cancer; 2014 Feb; 14():103. PubMed ID: 24548688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of Esophageal Cancer in the Republic of Uzbekistan from 2000 to 2018.
    Yusupbekov A; Kanda M; Usmanov B; Tuychiev O; Baymakov S; Sakamoto J; Yusupbekov A
    Asian Pac J Cancer Prev; 2020 Aug; 21(8):2281-2285. PubMed ID: 32856856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Esophageal Cancer Mortality and Stage at Diagnosis by Race and Ethnicity in the United States.
    Corona E; Yang L; Esrailian E; Ghassemi KA; Conklin JL; May FP
    Cancer Causes Control; 2021 Aug; 32(8):883-894. PubMed ID: 34003396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Squamous Cell Carcinoma of the Esophagus.
    Codipilly DC; Wang KK
    Gastroenterol Clin North Am; 2022 Sep; 51(3):457-484. PubMed ID: 36153105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive Genomic Profiling of Advanced Esophageal Squamous Cell Carcinomas and Esophageal Adenocarcinomas Reveals Similarities and Differences.
    Wang K; Johnson A; Ali SM; Klempner SJ; Bekaii-Saab T; Vacirca JL; Khaira D; Yelensky R; Chmielecki J; Elvin JA; Lipson D; Miller VA; Stephens PJ; Ross JS
    Oncologist; 2015 Oct; 20(10):1132-9. PubMed ID: 26336083
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal preoperative neoadjuvant therapy for resectable locally advanced esophageal squamous cell carcinoma.
    Leng XF; Daiko H; Han YT; Mao YS
    Ann N Y Acad Sci; 2020 Dec; 1482(1):213-224. PubMed ID: 33067818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer stem cells in esophageal cancer and response to therapy.
    Harada K; Pool Pizzi M; Baba H; Shanbhag ND; Song S; Ajani JA
    Cancer; 2018 Oct; 124(20):3962-3964. PubMed ID: 30368777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Verrucous esophageal carcinoma is a unique indolent subtype of squamous cell carcinoma: a systematic review and individual patient regression analysis.
    Li DK; Haffar S; Horibe M; Homsi HA; Zukerberg L; Murad MH; Visrodia KH; Gala M; Katzka DA; Bazerbachi F
    J Gastroenterol; 2021 Jan; 56(1):12-24. PubMed ID: 33079233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SEOM Clinical Guideline for the diagnosis and treatment of esophageal cancer (2016).
    Martin-Richard M; Díaz Beveridge R; Arrazubi V; Alsina M; Galan Guzmán M; Custodio AB; Gómez C; Muñoz FL; Pazo R; Rivera F
    Clin Transl Oncol; 2016 Dec; 18(12):1179-1186. PubMed ID: 27900538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Molecular Characterization of Genetic Abnormalities in Esophageal Squamous Cell Carcinoma May Foster the Development of Targeted Therapies.
    Testa U; Castelli G; Pelosi E
    Curr Oncol; 2023 Jan; 30(1):610-640. PubMed ID: 36661697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection and management of esophageal cancer.
    Margulies C; Kim R; Reynolds JC
    Compr Ther; 1996 Sep; 22(9):565-78. PubMed ID: 8902348
    [No Abstract]   [Full Text] [Related]  

  • 20. Should Multidisciplinary Treatment Differ for Esophageal Adenocarcinoma Versus Esophageal Squamous Cell Cancer?
    Cools-Lartigue J; Ferri L
    Ann Surg Oncol; 2019 Apr; 26(4):1014-1027. PubMed ID: 30675706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.